Postnatal lead exposure and the cholinergic system

Insights

Early lead (Pb) exposure in rats impaired learning and memory. Cholinergic drug treatments reversed these effects, suggesting lead-induced behavioral changes stem from impaired cholinergic function.

Area of Science:

  • Neuroscience
  • Toxicology
  • Behavioral Science

Background:

  • Early lead (Pb) exposure is linked to behavioral deficits.
  • Cholinergic system dysfunction has been proposed as a mechanism for these effects.

Purpose of the Study:

  • To investigate the role of cholinergic function in the behavioral effects of early lead exposure.
  • To determine if modulating cholinergic activity can ameliorate lead-induced behavioral impairments.

Main Methods:

  • Long-Evans hooded rat pups were exposed to lead (High Pb, low Pb, or control) via maternal milk for 25 days.
  • Animals were behaviorally tested at 65 days of age using tasks assessing passive avoidance, spontaneous alternation, and open field activity.
  • The effects of cholinergic agonist (physostigmine) and antagonist (scopolamine) were examined in control and lead-exposed rats.

Main Results:

  • Lead exposure impaired passive avoidance acquisition and spontaneous alternation but not open field activity.
  • Physostigmine improved behavioral deficits in lead-exposed rats.
  • Scopolamine mimicked some lead-induced deficits in control rats and showed complex effects in lead-exposed rats, suggesting an inverted U-shaped dose-response.

Conclusions:

  • Behavioral responses of lead-exposed rats are consistent with cholinergic deficiency.
  • These findings provide further evidence for the involvement of the cholinergic system in the behavioral consequences of early lead exposure.

Related Concept Videos

Toxic Reactions: Overview01:26

Toxic Reactions: Overview

When toxic substances penetrate the human body, they disseminate to various tissues, undergoing metabolic changes. This process yields reactive metabolites that may covalently bind with specific target molecules, resulting in toxicity.
Toxicity falls into two primary categories: local and systemic.
Local toxicity appears at the exposure site, such as protein denaturation caused by caustic substances.
In contrast, systemic toxicity requires the toxic agent's absorption and distribution,...
Cholinergic Neurons: Neurotransmission01:23

Cholinergic Neurons: Neurotransmission

Cholinergic neurotransmission involves the synthesis and the release of acetylcholine (ACh) in order to transmit nerve impulses across the synapse. The process begins with the synthesis of acetyl CoA, a precursor for ACh, from ATP, acetate, and coenzyme A in the mitochondria. Choline, another vital precursor, is transported inside the neuron through choline transporters, including high-affinity choline transporter CHT1, low-affinity choline transporter CTL1, and lower-affinity choline...
Direct-Acting Cholinergic Agonists: Pharmacokinetics01:31

Direct-Acting Cholinergic Agonists: Pharmacokinetics

Direct-acting cholinergic agonists, such as synthetic choline esters and naturally occurring alkaloids, exert their effects by enhancing the actions of acetylcholine and stimulating the parasympathetic nervous system. Synthetic choline esters share structural similarities with acetylcholine. For example, they have a positively charged quaternary ammonium or onium group, contributing to their hydrophilic characteristics. As a result, they are poorly absorbed in the body through oral...
Indirect-Acting Cholinergic Agonists: Pharmacological Actions01:30

Indirect-Acting Cholinergic Agonists: Pharmacological Actions

Indirect-acting cholinergic agonists, also known as anticholinesterases, exert their pharmacological effects by enhancing cholinergic transmission in various body parts, including the neuromuscular junction, autonomic cholinergic synapses, and the brain.
At the neuromuscular junction, these agents work by inhibiting the breakdown of acetylcholine, allowing it to remain bound to the receptor and bind to nearby receptors. This process leads to repetitive firing of the endplate, causing muscle...
Anticholinesterase Agents: Poisoning and Treatment01:26

Anticholinesterase Agents: Poisoning and Treatment

Anticholinesterases, also known as cholinesterase inhibitors, work by blocking the breakdown of acetylcholine, leading to its accumulation in the synaptic cleft. This accumulation indirectly enhances both muscarinic and nicotinic actions. These agents are classified as reversible or irreversible based on their mechanism of action.     
Irreversible agents form a strong bond with the cholinesterase enzyme, making it inactive. The breakdown of the phosphorylated enzyme is slower than the...
Attention-Deficit/Hyperactivity Disorder01:30

Attention-Deficit/Hyperactivity Disorder

Attention-deficit/hyperactivity disorder (ADHD) is a neurodevelopmental disorder characterized by persistent inattention, hyperactivity, and impulsivity. It affects approximately 5-8% of children globally, with around 60-70% of cases persisting into adulthood. ADHD has significant implications for educational attainment, social interactions, and occupational success.
Diagnostic Criteria and Symptoms
To diagnose ADHD, symptoms must manifest before age 12 and be evident across multiple settings.